[ Price : $8.95]
FDA cites PharmaTher over alleged misleading promotional claims for its generic ketamine.[ Price : $8.95]
Novo Nordisk says data from two global Phase 3 trials of semaglutide (Ozempic and Wegovy) have failed to slow clinical progression...[ Price : $8.95]
U.S. House and Senate health committee leaders express concern about a new FDA review pilot program because it appears designed to...[ Price : $8.95]
FDA investigators cite Molecular PharmaGroup, an outsourcing facility in New Providence, N.J., for multiple sterility and quality-...[ Price : $8.95]
FDA issues an early alert warning about a potentially high-risk defect in certain Fresenius Kabi Ivenix large volume pump primary ...[ Price : $8.95]
Johnson & Johnson discontinues its Auτonomy Phase 2b Alzheimers study after interim data showed its experimental antibody pos...[ Price : $8.95]
Three Harvard medical professors raise concerns over FDAs review voucher program that they say could politicize drug approvals and...[ Price : $8.95]
FDA posts a Federal Register notice finalizing the withdrawal of Intercept Pharmaceuticals Ocaliva (obeticholic acid) from the U.S...